-
Mesoblast (MESO) Added to Nasdaq Biotechnology Index
-
COMPASS Pathways plc (CMPS) to Join NASDAQ Biotechnology Index (NBI)
-
Zevra Therapeutics (ZVRA) to Join Nasdaq Biotechnology Index (NBI)
-
JPMorgan is out with its 2025 outlook for biotech stocks

